News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GE Healthcare Life SciencesOlivier Loeillot Appointed GM Asia Commercial Bioprocess


8/13/2014 12:57:41 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHALFONT ST. GILES, UK – 13 August 2014 – GE Healthcare Life Sciences today announced the appointment of Olivier Loeillot as General Manager, Asia Commercial for BioProcess. In this newly-created role Olivier will oversee commercial activities in the fast-moving Asian market for GE Healthcare Life Science’s rapidly growing BioProcess business, which provides innovative “start-to-finish” technologies and services for the biopharmaceutical and vaccine manufacturing industry. Olivier now reports to Emmanuel Ligner, GM Global Commercial BioProcess, and is based in Singapore. He takes on this responsibility in addition to his role as GM Enterprise Solutions.

GE Healthcare’s strategy of helping the biopharmaceutical industry improve product yields and reduce time-to-market is reflected in a series of recent developments in the Asian region. In September 2013, biopharmaceutical process development and manufacturing services provider JHL Biotech announced that the first of GE’s innovative KUBio™ modular facilities for monoclonal antibody production would be built at its site in Wuhan, China and then, in December 2013, that GE’s FlexFactory™ Biomanufacturing Platform had been successfully installed in its Taiwan facility.

Emmanuel Ligner, GM Global Commercial BioProcess, GE Healthcare Life Sciences, said: “The biopharmaceutical sector in Asia is seeing a lot of rapid growth and we are delighted that Olivier is heading up our efforts in this dynamic region. Olivier’s extensive experience in biopharmaceutical manufacturing will strengthen significantly our ability to serve our customers there.”

Olivier Loeillot, GM Asia Commercial BioProcess and GM Enterprise Solutions, GE Healthcare Life Sciences, said: “I’m looking forward to building on our existing relationships in the region. The deeper understanding gained from those interactions, combined with the solid foundation created by our Singapore and Shanghai Fast Trak Training Centres, will enable us to tailor our comprehensive offering according to the needs of the life sciences industry locally.”

Before taking on this additional Asian role, Olivier was General Manager for Enterprise Solutions, GE Healthcare Life Sciences. Prior to that he was at Lonza, where he held a series of senior leadership roles in general management, business development and sales. Loeillot earned his master’s degree in Chemistry in 1993 from The European High Institute of Chemistry of Strasbourg, France. He subsequently graduated from CESMA with a master’s degree in Business Administration.

- ENDS -

About GE Healthcare

GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

Issued for and on behalf of GE Healthcare by Instinctif Partners.

For more information or a high resolution image, please contact:

Contact:

GE Healthcare
Dr. Val Jones, Global Media Relations Manager
T +44 7917 175 192
E val.jones@ge.com
@GEHealthcare

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES